Cytokine gene expression after total hip arthroplasty: Surgical site versus circulating neutrophil response

Anesthesia and Analgesia

Volumn 109, Issue 3, 2009, Pages 959-964

  Buvanendran, Asokumar ^a   Mitchell, Kendall ^b   Kroin, Jeffrey S ^a   Iadarola, Michael J ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE P33; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18 RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; RNA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CCL20 PROTEIN, HUMAN; IL18R1 PROTEIN, HUMAN; IL18RAP PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; INTERLEUKIN 18 RECEPTOR BETA;

ADULT; AGED; ARTICLE; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; DNA MICROARRAY; DNA SEQUENCE; DOWN REGULATION; EOSINOPHIL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA PROBE; SURGICAL PATIENT; SURGICAL WOUND; TOTAL HIP PROSTHESIS; UPREGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; HIP ARTHROPLASTY; METABOLISM; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; CHEMOKINE CCL20; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-18 RECEPTOR BETA SUBUNIT; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; NEUTROPHILS;

EID: 70149123489     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181ac1746     Document Type: Article

References (31)

1. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative painexperience: results from a national survey suggest postoperativepain continues to be undermanaged. Anesth Analg 2003;97:534-40 (Pubitemid 36899761)
2. Buvanendran A, Kroin JS, Berger RA, Hallab NJ, Saha C,Negrescu C, Moric M, Caicedo MS, Tuman KJ. Upregulation ofprostaglandin E2 and interleukins in the central nervous systemand peripheral tissue during and after surgery in humans.Anesthesiology 2006;104:403-10
3. Diegelmann RF, Evans MC. Wound healing: an overview ofacute, fibrotic and delayed healing. Front Biosci 2004;9:283-9 (Pubitemid 38925460)
4. Englelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB,Gillitzer R. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Migare sequentially and differentially expressed during phasespecificinfiltration of leukocyte subsets in human woundhealing. Am J Pathol 1998;153:1849-60 (Pubitemid 28550672)
5. Gillitzer R, Goebeler M. Chemokines in cutaneous woundhealing. J Leukoc Biol 2001;69:513-21
6. Park JE, Barbul A. Understanding the role of immune regulationin wound healing. Am J Surg 2004;187:11S-16S (Pubitemid 38625982)
7. Cunha FQ, Ferreira SH. Peripheral hyperalgesic cytokines. AdvExp Med Biol 2003;521:22-39 (Pubitemid 36535162)
8. Rittner HL, Machelska H, Stein C. Leukocytes in the regulationof pain and analgesia. J Leukoc Biol 2005;78:1215-22
9. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW.Parallel human genome analysis: microarray-based expressionmonitoring of 1000 genes. Proc Natl Acad Sci USA 1996;93:10614-9 (Pubitemid 26333036)
10. Yang HY, Mitchell K, Keller JM, Iadarola MJ. Peripheral inflammationincreases Scya2 expression in sensory ganglia andcytokine and endothelial related gene expression in inflamedtissue. J Neurochem 2007;103:1628-43 (Pubitemid 47631824)
11. Calandra T, Roger T. Macrophage migration inhibitory factor: aregulator of innate immunity. Nat Rev Immunol 2003;3:791-800 (Pubitemid 37328657)
12. Meyer-Siegler KL, Vera PL. Intraluminal antibodies to macrophagemigration inhibitory factor decrease substance P inducedinflammatory changes in the rat bladder and prostate. J Urol2004;172:1504-9 (Pubitemid 39249758)
13. Akoum A, Metz CN, Al-Akoum M, Kats R. Macrophage migrationinhibitory factor expression in the intrauterine endometriumof women with endometriosis varies with disease stage,infertility status, and pelvic pain. Fertil Steril 2006;85:1379-85
14. Morin M, Bellehumeur C, Therriault MJ, Metz C, Maheux R,Akoum A. Elevated levels of macrophage migration inhibitoryfactor in the peripheral blood of women with endometriosis.Fertil Steril 2005;83:865-72
15. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ,Beach DH. A proinflammatory cytokine inhibits p53 tumorsuppressor activity. J Exp Med 1999;190:1375-82
16. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J,David J, Bucala R. Macrophage migration inhibitory factor(MIF) sustains macrophage proinflammatory function by inhibitingp53: regulatory role in the innate immune response. ProcNatl Acad Sci USA 2002;99:345-50 (Pubitemid 34060365)
17. Arend WP, Guthridge CJ. Biological role of interleukin 1 receptorantagonist isoforms. Ann Rheum Dis 2000;59(suppl 1):i60-4
18. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1beta as a potent hyperalgesic agent antagonized by a tripeptideanalogue. Nature 1988;334:698-700
19. Wolf G, Yirmiya R, Goshen I, Iverfeldt K, Holmlund L, TakedaK, Shavit Y. Impairment of interleukin-1 (IL-1) signaling reducesbasal pain sensitivity in mice: genetic, pharmacological anddevelopmental aspects. Pain 2003;104:471-80 (Pubitemid 37289046)
20. Baamonde A, Curto-Reyes V, Juarez L, Meana A, Hidalgo A,Menendez L. Antihyperalgesic effects induced by the IL-1 receptorantagonist anakinra and increased IL-1beta levels in inflamed andosteosarcoma-bearing mice. Life Sci 2007;81:673-82 (Pubitemid 47268018)
21. Furst DE. Anakinra: review of recombinant human interleukin-Ireceptor antagonist in the treatment of rheumatoid arthritis.Clin Ther 2004;26:1960-75 (Pubitemid 40353607)
22. Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA,Campbell C, Cunha F, Liew FY, McInnes IB. A role for IL-18 inneutrophil activation. J Immunol 2001;167:2879-86
23. Verri WA Jr, Schivo IR, Cunha TM, Liew FY, Ferreira SH, CunhaFQ. Interleukin-18 induces mechanical hypernociception in ratsvia endothelin acting on ETB receptors in a morphine-sensitivemanner. J Pharmacol Exp Ther 2004;310:710-7 (Pubitemid 38988917)
24. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure andfunctional expression of a human interleukin-8 receptor. Science1991;253:1278-80 (Pubitemid 21917277)
25. Murphy PM, Tiffany HL. Cloning of complementary DNAencoding a functional human interleukin-8 receptor. Science1991;253:1280-3 (Pubitemid 21917278)
26. Samanta AK, Oppenheim JJ, Matsushima K. Interleukin 8(monocyte-derived neutrophil chemotactic factor) dynamicallyregulates its own receptor expression on human neutrophils.J Biol Chem 1990;265:183-9
27. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8receptor A/B by IL-8: possible functions of each receptor.J Immunol 1995;155:2587-94
28. Schlenk J, Lorenz HM, Haas JP, Herrmann M, Hohenberger G,Kalden JR, Röllinghoff M, Beuscher HU. Extravasation intosynovial tissue induces CCL20 mRNA expression in polymorphonuclearneutrophils of patients with rheumatoid arthritis.J Rheumatol 2005;32:2291-8 (Pubitemid 41780636)
29. McGrory K, Flaitz CM, Klein JR. Chemokine changes duringoral wound healing. Biochem Biophys Res Commun 2004;324:317-20 (Pubitemid 39311496)
30. van Eeden SF, Klut ME, Walker BA, Hogg JC. The use of flowcytometry to measure neutrophil function. J Immunol Methods1999;232:23-43 (Pubitemid 30017763)
31. Høgevold HE, Lyberg T, Kähler H, Haug E, Reikerås O.Changes in plasma IL-1beta, TNF-alpha and IL-6 after total hipreplacement surgery in general or regional anaesthesia. Cytokine2000;12:1156-9 (Pubitemid 30479505)